Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 2/2019

01-02-2019 | Original Article

Risk factors for local recurrence following lateral neck dissection for papillary thyroid carcinoma

Authors: Marco Raffaelli, Carmela De Crea, Luca Sessa, Serena Elisa Tempera, Amanda Belluzzi, Celestino P. Lombardi, Rocco Bellantone

Published in: Endocrine | Issue 2/2019

Login to get access

Abstract

Purpose

We aimed to evaluate risk factors for local recurrence following lateral neck dissection (LND) for papillary thyroid carcinoma (PTC).

Methods

Two hundred and nine patients who underwent therapeutic primary or reoperative LND for PTC were included.

Results

One hundred eighty-one patients underwent primary LND at our Institution, the remaining 28 were referred for recurrence following LND outside the Institution. Comparing patients who required reoperation for recurrent lateral neck disease with those who did not recur, no significant difference was found concerning sex, tumor size, multifocal disease, extracapsular invasion, histological variant, pT stage (P = NS). At univariate analysis, age, mean number of removed lateral neck nodes at first operation, the extent of initial LND and surgery performed outside the Institution were risk factors for recurrence (P < 0.001).

Conclusions

Limited LND and surgery performed at non referral Centers were non tumor-related risk factors for recurrence following therapeutic LND for PTC.
Literature
1.
A.R. Shaha, J.P. Shah, T.R. Loree, Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid. Am. J. Surg. 172(6), 692–694 (1996)CrossRefPubMed
2.
J.L. Roh, J.Y. Park, C.I. Park, Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann. Surg. 245(4), 604–610 (2007)CrossRefPubMedPubMedCentral
3.
L.Y. Wang, F.L. Palmer, I.J. Nixon et al., Lateral neck lymph node characteristics prognostic of outcome in patients with clinically evident N1b papillary thyroid cancer. Ann. Surg. Oncol. 22(11), 3530–3536 (2015)CrossRefPubMedPubMedCentral
4.
C.W. Lee, J.L. Roh, G. Gong et al., Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck. Ann. Surg. Oncol. 22, 117–124 (2015)CrossRefPubMed
5.
Y.M. Lee, T.Y. Sung, W.B. Kim, K.W. Chung, J.H. Yoon, S.J. Hong, Risk factors for recurrence in patients with papillary thyroid carcinoma undergoing modified radical neck dissection. Br. J. Surg. 103(8), 1020–1025 (2016)CrossRefPubMed
6.
V. Zaydfudim, I.D. Feurer, M.R. Griffin, J.E. Phay, The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 144(6), 1070–1077 (2008). discussion 1077-1078CrossRefPubMed
7.
D.F. Schneider, H. Chen, R.S. Sippel, Impact of lymph node ratio on survival in papillary thyroid cancer. Ann. Surg. Oncol. 20(6), 1906–1911 (2013)CrossRefPubMed
8.
K. Segal, R. Friedental, E. Lubin, J. Shvero, J. Sulkes, R. Feinmesser, Papillary carcinoma of the thyroid. Otolaryngol. Head. Neck. Surg. 113, 356–363 (1995)CrossRefPubMed
9.
Y. Ito, T. Kudo, Y. Takamura, K. Kobayashi, A. Miya, A. Miyauchi, Lymph node recurrence in patients with N1b papillary thyroid carcinoma who underwent unilateral therapeutic modified radical neck dissection. World J. Surg. 36, 593–597 (2012)CrossRefPubMed
10.
C.P. Lombardi, M. Raffaelli, C. De Crea, L. Sessa, R. Bellantone, Morbidity of central neck dissection: primary surgery vs reoperation. Results a case-control study. Arch. Surg. 399, 747–753 (2014)CrossRef
11.
Y. Ito, T. Higashiyama, Y. Takamura et al., Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral neck node metastasis: validity of prophylactic modified radical neck dissection. World J. Surg. 31(11), 2085–2091 (2007)CrossRefPubMed
12.
M. Javid, E. Graham, J. Malinowski et al., Dissection of levels II through V is required for optimal outcomes in patients with lateral neck lymph node metastasis from papillary thyroid carcinoma. J. Am. Coll. Surg. 222(6), 1066–1073 (2016)CrossRefPubMed
13.
B.R. Haugen, E.K. Alexander, K.C. Bible et al., 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26, 1–133 (2016)CrossRefPubMedPubMedCentral
14.
F. Pacini, M. Schlumberger, H. Dralle et al., European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur. J. Endocrinol. 154, 787–803 (2016)CrossRef
15.
P. Perros, K. Boelaert, S. Colley et al., British Thyroid Association. Guidelines for the management of thyroid cancer. Clin. Endocrinol. 81(Suppl 1), 1–122 (2014)CrossRef
16.
B.C. Stack, R.L. Ferris, D. Goldenberg et al., American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid 22, 501–508 (2012)CrossRefPubMed
17.
C.P. Hasney, R.G. Amedee, What is the appropriate extent of lateral neck dissection in the treatment of metastatic well-differentiated thyroid carcinoma? Laryngoscope 120(9), 1716–1717 (2010)CrossRefPubMed
18.
N.R. Caron, Y.Y. Tan, J.B. Ogilvie et al., Selective Modified Radical Neck Dissection for Papillary Thyroid Cancer—Is Level I, II and V Dissection Always Necessary? World J. Surg. 30, 833–840 (2006)CrossRefPubMed
19.
M.L. Urken, M. Milas, G.W. Randolph et al., Management of recurrent and persistent metastatic lymph nodes in well-differentiated thyroid cancer: a multifactorial decision-making guide for the Thyroid Cancer Care Collaborative. Head. Neck 37(4), 605–614 (2015)CrossRefPubMed
20.
A. Machens, R. Hinze, O. Thomusch, H. Dralle, Pattern of Nodal Metastasis for Primary and Reoperative Thyroid Cancer. World J. Surg. 26, 22–28 (2002)CrossRefPubMed
21.
D.M. Hartl, S. Leboulleux, A.A. Ghuzlan et al., Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma. Ann. Surg. 255, 777–783 (2012)CrossRefPubMed
22.
A. Ohshima, H. Yamashita, S. Noguchi et al., Is a bilateral modified radical neck dissection beneficial for patients with papillary thyroid cancer? Surg. Today 32, 1027–1030 (2002)CrossRefPubMed
23.
S. Uchino, S. Noguchi, H. Yamashita, S. Watanabe, Modified radical neck dissection for differentiated thyroid cancer: operative technique. World J. Surg. 28, 1199–1203 (2004)CrossRefPubMed
24.
J.R. Porterfield, D.A. Factor, C.S. Grant, Operative technique for modified radical neck dissection in papillary thyroid carcinoma. Arch. Surg. 144(6), 567–574 (2009)CrossRefPubMed
25.
T. Farrag, F. Lin, N. Brownlee, Is routine dissection of level II-B and V-A necessary in patients with papillary thyroid cancer undergoing lateral neck dissection for FNA-confirmed metastases in other levels. World J. Surg. 33, 1680–1683 (2009)CrossRefPubMed
26.
M. Merdad, A. Eskander, T. Kroeker, J.L. Freeman, Predictors of level II and Vb neck disease in metastatic papillary thyroid cancer. Arch. Otolaryngol. Head. Neck Surg. 138(11), 1030–1033 (2012)CrossRefPubMed
27.
K. Welch, C.R. McHenry, Selective lateral compartment neck dissection for thyroid cancer. J. Surg. Res. 184(1), 193–199 (2013)CrossRefPubMed
28.
D.T. Hughes, A.M. Laird, B.S. Miller, P.G. Gauger, G.M. Doherty, Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin. Ann. Surg. Oncol. 19, 2951–2957 (2012)CrossRefPubMed
29.
M. Salvatori, M. Raffaelli, P. Castaldi et al., Evaluation of the surgical completeness after total thyroidectomy for differentiated thyroid carcinoma. Eur. J. Surg. Oncol. 33, 648–654 (2007)CrossRefPubMed
30.
American Joint Committee on Cancer. Thyroid. AJCC Cancer Staging Manual. 7th edn., Springer, New York. pp. 87−92 (2010)
31.
M. Raffaelli, C. De Crea, L. Sessa, G. Fadda, C. Bellantone, C.P. Lombardi, Ipsilateral central neck dissection plus frozen section examination versus prophylactic bilateral central neck dissection in cN0 papillary thyroid carcinoma. Ann. Surg. Oncol. 22, 2302–2308 (2015)CrossRefPubMed
32.
C.P. Lombardi, M. Raffaelli, C. De Crea et al., Report on 8 years of experience with video assisted thyroidectomy for papillary thyroid carcinoma. Surgery 142, 944–951 (2007)CrossRefPubMed
33.
N. Chéreau, C. Buffet, C. Trésallet, F. Tissier, L. Leenhardt, F. Menegaux, Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management. Surgery 159(3), 755–762 (2016)CrossRefPubMed
34.
J.Y. Park, B.S. Koo, Individualized optimal surgical extent of the lateral neck in papillary thyroid cancer with lateral cervical metastasis. Eur. Arch. Otorhinolaryngol. 271(6), 1355–1360 (2014)CrossRefPubMed
35.
F.F. Palazzo, J. Gosnell, R. Savio et al., Lymphadenectomy for papillary thyroid cancer: changes in practice over four decades. Eur. J. Surg. Oncol. 32(3), 340–344 (2006)CrossRefPubMed
Metadata
Title
Risk factors for local recurrence following lateral neck dissection for papillary thyroid carcinoma
Authors
Marco Raffaelli
Carmela De Crea
Luca Sessa
Serena Elisa Tempera
Amanda Belluzzi
Celestino P. Lombardi
Rocco Bellantone
Publication date
01-02-2019
Publisher
Springer US
Published in
Endocrine / Issue 2/2019
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-018-1788-9

Other articles of this Issue 2/2019

Endocrine 2/2019 Go to the issue

Correction

Correction to: Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: influence of the disease severity and therapy on the ovarian reserve

Original Article

Changes in metabolic parameters and cardiovascular risk factors after therapeutic control of acromegaly vary with the treatment modality. Data from the Bicêtre cohort, and review of the literature

Original Article

Effect of metformin on blood pressure in patients with hypertension: a randomized clinical trial

Original Article

Effects of combined menaquinone-4 and PTH1–34 treatment on osetogenesis and angiogenesis in calvarial defect in osteopenic rats

Original Article

Molecular genetics and phenotype/genotype correlation of 5-α reductase deficiency in a highly consanguineous population

Original Article

T2-weighted magnetic resonance imaging characterization of prolactinomas and association with their response to dopamine agonists

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits